Status:
UNKNOWN
Pharmacokinetics and Dynamics of Nebulized Dexmedetomidine
Lead Sponsor:
Assiut University
Conditions:
Abdominal Cancer
Eligibility:
All Genders
3-7 years
Phase:
PHASE1
PHASE2
Brief Summary
the aim of this study is to study the pharmacokinetics and dynamics of nebulized dexmetedomidine in children undergoing major abdominal cancer surgery.
Detailed Description
Inhalation of nebulized drug is an alternative route of administration that is relatively easy to set up, does not require venpuncture, but is associated with high bioavailability of the administered ...
Eligibility Criteria
Inclusion
- child aged 2-7 years
- ASA I or II
- scheduled for abdominal surgery
- with average weight, height, normal serum albumin
Exclusion
- patients with allergy to the study drug
- patients with significant organ dysfunction
- patients with cardiac arrhythmia
- patients with congenital heart disease
- use of psychotropic medication and mental retardation.
Key Trial Info
Start Date :
December 10 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2021
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT03762785
Start Date
December 10 2018
End Date
January 1 2021
Last Update
January 10 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
South Egypt Cancer Institute
Asyut, Egypt, 11715